To assess liver damage and hepatocyte apoptosis, we measured serum CK-18 levels, which have been recently reported to predict histological NASH and severity of liver disease in patients with NAFLD [7, 26]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.